George A. Scangos's most recent trade in Voyager Therapeutics Inc was a trade of 30,000 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 9, 2026.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Voyager Therapeutics Inc | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 Jun 2026 | 30,000 | 30,000 | - | - | Stock Option (Right to Buy) | |
| Agilent Tech | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 111.75 per share. | 19 Mar 2026 | 2,158 | 22,800 (0%) | 0% | 111.8 | 241,157 | Common Stock |
| Agilent Tech | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 111.75 per share. | 19 Mar 2026 | 1,057 | 23,857 (0%) | 0% | 111.8 | 118,120 | Common Stock |
| Voyager Therapeutics Inc | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 03 Jun 2025 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Agilent Tech | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 121.18 per share. | 14 Mar 2025 | 1,819 | 20,493 (0%) | 0% | 121.2 | 220,426 | Common Stock |
| Vir biotech Inc | George A. Scangos | Director | Sale of securities on an exchange or to another person at price $ 9.45 per share. | 24 Feb 2025 | 10,056 | 698,239 (0%) | 0% | 9.5 | 95,063 | Common Stock |
| Vir biotech Inc | George A. Scangos | Director | Sale of securities on an exchange or to another person at price $ 9.81 per share. | 18 Feb 2025 | 10,964 | 708,295 (0%) | 0% | 9.8 | 107,575 | Common Stock |
| Vir biotech Inc | George A. Scangos | Director | 23 Oct 2024 | 598,270 | 598,270 (0%) | 0% | 0 | Common Stock | ||
| Vir biotech Inc | George A. Scangos | Director | 23 Oct 2024 | 598,270 | 719,259 (0%) | 0% | 0 | Common Stock | ||
| Vir biotech Inc | George A. Scangos | Director | 23 Oct 2024 | 598,270 | 1,151,730 (1%) | 0% | 0 | Common Stock | ||
| Vir biotech Inc | George A. Scangos | Director | 23 Oct 2024 | 598,270 | 1,151,730 (1%) | 0% | 0 | Common Stock | ||
| Voyager Therapeutics Inc | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 05 Jun 2024 | 24,000 | 24,000 | - | - | Stock Option (Right to Buy) | |
| Vir biotech Inc | George A. Scangos | Director | 30 May 2024 | 16,000 | 16,000 | - | - | Stock Option (Right to Buy) | ||
| Vir biotech Inc | George A. Scangos | Director | 30 May 2024 | 8,000 | 120,989 (0%) | 0% | 0 | Common Stock | ||
| Agilent Tech | George A. Scangos | Director | Gift of securities by or to the insider at price $ 145.48 per share. | 29 May 2024 | 3,443 | 18,577 (0%) | 0% | 145.5 | 500,888 | Common Stock |
| Agilent Tech | George A. Scangos | Director | Gift of securities by or to the insider at price $ 145.48 per share. | 29 May 2024 | 3,443 | 17,893 (0%) | 0% | 145.5 | 500,888 | Common Stock |
| Agilent Tech | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 147.48 per share. | 15 Mar 2024 | 1,678 | 21,989 (0%) | 0% | 147.5 | 247,471 | Common Stock |
| Vir biotech Inc | A. George Scangos | Director | 22 Feb 2024 | 17,722 | 112,989 (0%) | 0% | 11.7 | 206,522 | Common Stock | |
| Vir biotech Inc | Scangos A. George | Director | 22 Feb 2024 | 10,028 | 130,711 (0%) | 0% | 10.0 | 100,737 | Common Stock | |
| Vir biotech Inc | Scangos George A. | Director | 16 Feb 2024 | 16,872 | 140,739 (0%) | 0% | 10.2 | 172,385 | Common Stock | |
| Vir biotech Inc | A. George Scangos | Director | 16 Feb 2024 | 10,878 | 157,611 (0%) | 0% | 10.2 | 111,386 | Common Stock | |
| Voyager Therapeutics Inc | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 06 Jun 2023 | 22,000 | 22,000 | - | - | Stock Option (Right to Buy) | |
| Voyager Therapeutics Inc | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 09 May 2023 | 44,000 | 44,000 | - | - | Stock Option (Right to Buy) | |
| Agilent Tech | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 136.82 per share. | 16 Mar 2023 | 1,658 | 20,184 (0%) | 0% | 136.8 | 226,848 | Common Stock |
| Vir biotech Inc | George A. Scangos | Director, President and CEO | 23 Feb 2023 | 12,631 | 183,608 (0%) | 0% | 26.0 | 328,065 | Common Stock | |
| Vir biotech Inc | George A. Scangos | Director, President and CEO | 23 Feb 2023 | 10,880 | 168,489 (0%) | 0% | 23.6 | 256,300 | Common Stock | |
| Vir biotech Inc | George A. Scangos | Director, President and CEO | 23 Feb 2023 | 4,239 | 179,369 (0%) | 0% | 22.7 | 96,382 | Common Stock | |
| Vir biotech Inc | George A. Scangos | Director, President and CEO | 17 Feb 2023 | 64,930 | 179,930 (0%) | 0% | 0 | Common Stock | ||
| Vir biotech Inc | George A. Scangos | Director, President and CEO | 17 Feb 2023 | 64,930 | 3,533,629 (3%) | 0% | 0 | Common Stock | ||
| Vir biotech Inc | George A. Scangos | Director, President and CEO | 17 Feb 2023 | 49,984 | 111,644 (0%) | 0% | 0 | Common Stock | ||
| Vir biotech Inc | George A. Scangos | Director, President and CEO | 17 Feb 2023 | 49,984 | 111,644 (0%) | 0% | 0 | Common Stock | ||
| Vir biotech Inc | George A. Scangos | Director, President and CEO | 17 Feb 2023 | 49,984 | 827,151 (0%) | 0% | 0 | Common Stock | ||
| Vir biotech Inc | George A. Scangos | Director, President and CEO | 17 Feb 2023 | 49,984 | 827,151 (0%) | 0% | 0 | Common Stock | ||
| Vir biotech Inc | George A. Scangos | Director, President and CEO | 17 Feb 2023 | 11,382 | 202,713 (0%) | 0% | 28.0 | 318,867 | Common Stock | |
| Vir biotech Inc | George A. Scangos | Director, President and CEO | 17 Feb 2023 | 9,894 | 214,095 (0%) | 0% | 25.3 | 250,199 | Common Stock | |
| Vir biotech Inc | George A. Scangos | Director, President and CEO | 17 Feb 2023 | 6,474 | 196,239 (0%) | 0% | 28.8 | 186,451 | Common Stock | |
| Agilent Tech | George A. Scangos | Director | Grant, award, or other acquisition of securities at price $ 136.82 per share. | 17 Mar 2022 | 1,785 | 18,419 (0%) | 0% | 136.8 | 244,224 | Common Stock |
| Vir biotech Inc | George A. Scangos | Director, President and CEO | 10 Mar 2022 | 222,000 | 222,000 | - | - | Stock Option (Right to Buy) | ||
| Vir biotech Inc | George A. Scangos | Director, President and CEO | 10 Mar 2022 | 111,000 | 223,989 (0%) | 0% | 0 | Common Stock | ||
| Vir biotech Inc | George A. Scangos | Director, President and CEO | 17 Feb 2022 | 17,726 | 112,989 (0%) | 0% | 30.7 | 543,304 | Common Stock | |
| Vir biotech Inc | George A. Scangos | Director, President and CEO | 17 Feb 2022 | 10,024 | 130,715 (0%) | 0% | 31.9 | 320,074 | Common Stock |